Skip to main content

Articles

Page 62 of 74

  1. Many people with clinically significant chronic obstructive pulmonary disease (COPD) remain undiagnosed worldwide. There are a number of small studies which have examined possible methods of case finding throu...

    Authors: Rachel E Jordan, Peymané Adab, Sue Jowett, Jen L Marsh, Richard D Riley, Alexandra Enocson, Martin R Miller, Brendan G Cooper, Alice M Turner, Jon G Ayres, Kar Keung Cheng, Kate Jolly, Robert A Stockley, Sheila Greenfield, Stanley Siebert, Amanda Daley…
    Citation: BMC Pulmonary Medicine 2014 14:157
  2. The surgical resection of lung disrupts glucose homeostasis and causes hyperglycemia, as in any other major surgery or critical illness. We performed a prospective study where we carefully lowered hyperglycemi...

    Authors: Zdenek Ručka, Irena Koutná, Lenka Tesařová, Michaela Potěšilová, Stanislav Stejskal, Pavel Šimara, Petr Vaňhara, Jan Doležel, Vaclav Zvoníček, Oldřich Coufal and Ivan Čapov
    Citation: BMC Pulmonary Medicine 2014 14:155
  3. Exposure to perinatal anxiety affects disease susceptibility in offspring but studies on the association between perinatal anxiety and gene polymorphisms are lacking. This study aimed to elucidate the interact...

    Authors: Eun Lee, Hyoung Yoon Chang, Kyung-Sook Lee, Dong In Suh, Ho-Sung Yu, Mi-Jin Kang, In Ae Choi, Jinah Park, Kyung Won Kim, Youn Ho Shin, Kang Mo Ahn, Ja-Young Kwon, Suk-Joo Choi, Kyung-Ju Lee, Hye-Sung Won, Song I Yang…
    Citation: BMC Pulmonary Medicine 2014 14:154
  4. This retrospective cohort study aimed to determine if there are differences in cardiovascular co-morbidities, blood pressure (BP) and continuous positive airway pressure (CPAP) use between patients with positi...

    Authors: Yi-Chih Huang, Chun-Yao Lin, Chou-Chin Lan, Yao-Kuang Wu, Chor-Shen Lim, Chun-Yao Huang, Hsuan-Li Huang, Kuan-Hung Yeh, Yu-Chih Liu and Mei-Chen Yang
    Citation: BMC Pulmonary Medicine 2014 14:153
  5. Nucleotide-binding oligomerizing domain-1 (NOD1) is a cytoplasmic receptor involved in recognizing bacterial peptidoglycan fragments that localize to the cytosol. NOD1 activation triggers inflammation, antimic...

    Authors: Esmeralda Juárez, Claudia Carranza, Fernando Hernández-Sánchez, Elva Loyola, Dante Escobedo, Juan Carlos León-Contreras, Rogelio Hernández-Pando, Martha Torres and Eduardo Sada
    Citation: BMC Pulmonary Medicine 2014 14:152
  6. Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide. Patients with COPD frequently have systemic comorbidities that often require unscheduled hospitalization for exacerbation a...

    Authors: Wakae Hasegawa, Yasuhiro Yamauchi, Hideo Yasunaga, Mitsuhiro Sunohara, Taisuke Jo, Hiroki Matsui, Kiyohide Fushimi, Kazutaka Takami and Takahide Nagase
    Citation: BMC Pulmonary Medicine 2014 14:151
  7. Pulmonary exacerbation is one of the main risk factors for death in patients with cystic fibrosis. Several biomarkers have proven useful in the diagnosis and treatment of pulmonary exacerbations, although none...

    Authors: Rosa Maria Girón-Moreno, José L Justicia, Sara Yamamoto, Claudia Valenzuela, Carolina Cisneros, Rosa Mar Gómez-Punter, Gilda Fernandes-Vasconcelos and Julio Ancochea
    Citation: BMC Pulmonary Medicine 2014 14:150
  8. ATS/ERS Task Force has highlighted that special attention must be paid when FEV1 and FVC are concomitantly decreased (<5th percentile) and the FEV1/FVC ratio is normal (>5th percentile) because a possible cause o...

    Authors: Brigitte Chevalier-Bidaud, Karine Gillet-Juvin, Etienne Callens, Romain Chenu, Sémia Graba, Mohamed Essalhi and Christophe Delclaux
    Citation: BMC Pulmonary Medicine 2014 14:148
  9. Indoor particulate matter (PM) has been linked to respiratory symptoms in former smokers with COPD. While subjects with COPD and atopy have also been shown to have more frequent respiratory symptoms, whether t...

    Authors: Deepak A Kaji, Andrew J Belli, Meredith C McCormack, Elizabeth C Matsui, D’Ann L Williams, Laura Paulin, Nirupama Putcha, Roger D Peng, Gregory B Diette, Patrick N Breysse and Nadia N Hansel
    Citation: BMC Pulmonary Medicine 2014 14:147
  10. Strength training and neuromuscular electrical stimulation (NMES) are effective training modalities for improving muscle function, exercise performance and health status in individuals with COPD. The aim of th...

    Authors: Maurice JH Sillen, Frits ME Franssen, Anouk W Vaes, Jeannet ML Delbressine, Emiel FM Wouters and Martijn A Spruit
    Citation: BMC Pulmonary Medicine 2014 14:146
  11. Thyroid dysfunction has been described to be linked to a variety of cardiovascular morbidities. Through this pathway thyroid function might also be associated with cardiorespiratory function and exercise capac...

    Authors: Till Ittermann, Sven Gläser, Ralf Ewert, Stephan Felix, Henry Völzke and Marcus Dörr
    Citation: BMC Pulmonary Medicine 2014 14:145
  12. Viral pathogens were more commonly reported than previously estimated in community-acquired pneumonia (CAP) patients. However, the real role of virus was still controversial.

    Authors: Yangqing Zhan, Zifeng Yang, Rongchang Chen, Yutao Wang, Wenda Guan and Suishan Zhao
    Citation: BMC Pulmonary Medicine 2014 14:144
  13. Angiopoietin-1 (Ang-1) is an essential mediator of angiogenesis that establishes vascular integrity, and angiopoietin-2 (Ang-2) acts as its natural inhibitor. We considered that angiopoietin might be important...

    Authors: Kuk-Young Moon, PuReun-HaNeul Lee, Sung-Woo Park, Choon-Sik Park and An-Soo Jang
    Citation: BMC Pulmonary Medicine 2014 14:143
  14. Moderate-intensity exercise training improves skeletal muscle aerobic capacity and increased oxidative enzyme activity, as well as exercise tolerance in COPD patients.

    Authors: Chun-Hua Wang, Pai-Chien Chou, Wen-Ching Joa, Li-Fei Chen, Te-Fang Sheng, Shu-Chuan Ho, Horng-Chyuan Lin, Chien-Da Huang, Fu-Tsai Chung, Kian Fan Chung and Han-Pin Kuo
    Citation: BMC Pulmonary Medicine 2014 14:142
  15. Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term complication following an acute pulmonary embolism (PE). It is frequently diagnosed at advanced stages which is concerning as delayed treatm...

    Authors: Matthias Held, Alexander Hesse, Franziska Gött, Regina Holl, Gudrun Hübner, Philipp Kolb, Heinz Jakob Langen, Tobias Romen, Franziska Walter, Hans Joachim Schäfers, Heinrike Wilkens and Berthold Jany
    Citation: BMC Pulmonary Medicine 2014 14:141
  16. Sleep-related breathing disorders (SRBDs) provoke cognitive and structural brain disorders. Because these disorders have been associated with unsafe gait characterized by an increase in stride-to-stride variab...

    Authors: Sébastien Celle, Cédric Annweiler, Richard Camicioli, Jean-Claude Barthélémy, Frédéric Roche and Olivier Beauchet
    Citation: BMC Pulmonary Medicine 2014 14:140
  17. Idiopathic pulmonary fibrosis (IPF) is a distinct form of interstitial pneumonia with unknown origin and poor prognosis. Current pharmacologic treatments are limited and lung transplantation is a viable option...

    Authors: Kristin D Kistler, Luba Nalysnyk, Philip Rotella and Dirk Esser
    Citation: BMC Pulmonary Medicine 2014 14:139
  18. Solitary fibrous tumors of the pleura (SFTP) are rare and their long-term outcome is difficult to predict, as there are insufficient data which allow accurate characterization of the malignant variant. Thus th...

    Authors: Daniel Franzen, Matthias Diebold, Alex Soltermann, Didier Schneiter, Peter Kestenholz, Rolf Stahel, Walter Weder and Malcolm Kohler
    Citation: BMC Pulmonary Medicine 2014 14:138
  19. Fiberoptic bronchoscopy (FOB) is a useful diagnosis tool in low-burden countries for patients with suspected pulmonary tuberculosis (TB) who are smear-negative or sputum-scarce. This study sought to determine ...

    Authors: Pierre Le Palud, Vincent Cattoir, Brigitte Malbruny, Romain Magnier, Karine Campbell, Youssef Oulkhouir, Gérard Zalcman and Emmanuel Bergot
    Citation: BMC Pulmonary Medicine 2014 14:137
  20. The 6-minute walk test (6MWT) is used to measure exercise capacity and assess prognosis in interstitial lung disease (ILD). Although the 6MWT is usually considered to be a test of submaximal exercise capacity ...

    Authors: Anne E Holland, Leona Dowman, Julio Fiore Jr, Danny Brazzale, Catherine J Hill and Christine F McDonald
    Citation: BMC Pulmonary Medicine 2014 14:136
  21. Acute respiratory distress syndrome (ARDS) is characterized by overwhelming inflammatory responses and lung remodeling. We hypothesized that leukocyte infiltration during the inflammatory response modulates ep...

    Authors: Qiuhua Chen, Alice Aili Luo, Haibo Qiu, Bing Han, Bruce Hsin-Kuo Ko, Arthur S Slutsky and Haibo Zhang
    Citation: BMC Pulmonary Medicine 2014 14:135
  22. It is widely recognized that health-related quality of life (HRQL) is impaired in patients with Chronic Obstructive Pulmonary Disease (COPD), but there is a lack of research on longitudinal associations of COP...

    Authors: Margarethe E Wacker, Matthias Hunger, Stefan Karrasch, Joachim Heinrich, Annette Peters, Holger Schulz and Rolf Holle
    Citation: BMC Pulmonary Medicine 2014 14:134
  23. Being a contact of a pulmonary tuberculosis (TB) case is a risk factor for active and latent TB. The objective of this study is to determine the contact tracing yield using two different programmatic definitio...

    Authors: Carla Loredo, Michelle Cailleaux–Cezar, Anne Efron, Fernanda Carvalho Queiroz de Mello and Marcus Barreto Conde
    Citation: BMC Pulmonary Medicine 2014 14:133
  24. Inheritance of the F variant of alpha-1-antitrypsin is associated with normal circulating protein levels, but it is believed to be dysfunctional in its ability to inhibit neutrophil elastase and therefore has ...

    Authors: Nicola Jane Sinden, Firas Koura and Robert Andrew Stockley
    Citation: BMC Pulmonary Medicine 2014 14:132
  25. Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of treating COPD is to maintain or improv...

    Authors: Annerika HM Slok, Johannes CCM in ’t Veen, Niels H Chavannes, Thys van der Molen, Maureen PMH Rutten-van Mölken, Huib AM Kerstjens, Guus M Asijee, Philippe L Salomé, Sebastiaan Holverda, Richard PN Dekhuijzen, Denise Schuiten, Gerard van Breukelen, Daniel Kotz and Onno CP van Schayck
    Citation: BMC Pulmonary Medicine 2014 14:131
  26. Air pollution has many negative health effects on the general population, especially children, subjects with underlying chronic disease and the elderly. The aims of this study were to evaluate the effects of t...

    Authors: Susanna Esposito, Carlotta Galeone, Mara Lelii, Benedetta Longhi, Beatrice Ascolese, Laura Senatore, Elisabetta Prada, Valentina Montinaro, Stefano Malerba, Maria Francesca Patria and Nicola Principi
    Citation: BMC Pulmonary Medicine 2014 14:130
  27. Serum KL-6 is a useful biomarker for the diagnosis of interstitial lung diseases (ILD). However, KL-6 has not been used to discriminate different types of ILD. Serum KL-6 concentrations can vary depending on a...

    Authors: Hiroshi Ohnishi, Shintaro Miyamoto, Shigeo Kawase, Tetsuya Kubota and Akihito Yokoyama
    Citation: BMC Pulmonary Medicine 2014 14:129
  28. Bacteremia by Streptococcus pneumoniae has been traditionally associated with poor outcomes in patients with pneumonia; however, data on its impact on outcomes are limited and are sometimes contradictory.

    Authors: Alberto Capelastegui, Rafael Zalacain, Amaia Bilbao, Mikel Egurrola, Luis Alberto Ruiz Iturriaga, Jose M Quintana, Ainhoa Gomez, Cristobal Esteban and Pedro P España
    Citation: BMC Pulmonary Medicine 2014 14:128
  29. Long term oxygen therapy (LTOT) has a strong evidence base in COPD patients with respiratory failure, but prescribing practices are recognized to need reform to ensure appropriate use and minimize costs. In th...

    Authors: Alice M Turner, Sourav Sen, Cathryn Steeley, Yasmin Khan, Pamela Sweeney, Yvonne Richards and Rahul Mukherjee
    Citation: BMC Pulmonary Medicine 2014 14:127
  30. Nitric oxide can be measured at multiple flow rates to determine proximal (maximum airway nitric oxide flux; JawNO) and distal inflammation (alveolar nitric oxide concentration; CANO). The main aim was to study t...

    Authors: Olaia Sardón, Paula Corcuera, Ane Aldasoro, Javier Korta, Javier Mintegui, José I Emparanza and Eduardo G Pérez-Yarza
    Citation: BMC Pulmonary Medicine 2014 14:126
  31. The effectiveness of clinic-based pulmonary rehabilitation in advanced COPD is well established, but few data exist for less severe patients treated in alternative settings. The purpose of this study was to in...

    Authors: Shefalee Amin, Marlon Abrazado, Molly Quinn, Thomas W Storer, Chi-Hong Tseng and Christopher B Cooper
    Citation: BMC Pulmonary Medicine 2014 14:125
  32. Patients with COPD are at risk of non-tuberculous mycobacterial infection (NTM). This study examined the histology of lung tissue from COPD patients following lung volume reduction with particular focus on evi...

    Authors: Anjali Char, Nick S Hopkinson, David M Hansell, Andrew G Nicholson, Emily C Shaw, Samuel J Clark, Philip Sedgwick, Robert Wilson, Simon Jordan and Michael R Loebinger
    Citation: BMC Pulmonary Medicine 2014 14:124
  33. The role of mixed pneumonia (virus + bacteria) in community-acquired pneumonia (CAP) has been described in recent years. However, it is not known whether the systemic inflammatory profile is different compared...

    Authors: Salvador Bello, Elisa Mincholé, Sergio Fandos, Ana B Lasierra, María A Ruiz, Ana L Simon, Carolina Panadero, Carlos Lapresta, Rosario Menendez and Antoni Torres
    Citation: BMC Pulmonary Medicine 2014 14:123
  34. Eotaxin proteins are a potential therapeutic target in treating the peribronchial eosinophilia associated with allergic airway diseases. Since inflammation is often associated with an increased generation of r...

    Authors: In-Hee Cho, Ju-Hyun Gong, Min-Kyung Kang, Eun-Jung Lee, Jung Han Yoon Park, Sang-Jae Park and Young-Hee Kang
    Citation: BMC Pulmonary Medicine 2014 14:122
  35. Systemic inflammation plays an important role in the initiation, promotion, and progression of lung carcinogenesis. In patients with non-small cell lung cancer (NSCLC), fibrinogen levels correlate with neoplas...

    Authors: Maria Tereza Aguiar Pessoa Morano, Rafael Mesquita, Guilherme Pinheiro Ferreira Da Silva, Amanda Souza Araújo, Juliana Maria De Sousa Pinto, Antero Gomes Neto, Cyntia Maria Sampaio Viana, Manoel Odorico De Moraes Filho and Eanes Delgado Barros Pereira
    Citation: BMC Pulmonary Medicine 2014 14:121
  36. Idiopathic pulmonary fibrosis (IPF) is a progressive parenchymal lung disease of unknown aetiology and poor prognosis, characterized by altered tissue repair and fibrosis. The extracellular matrix (ECM) is a c...

    Authors: Susanna Estany, Vanesa Vicens-Zygmunt, Roger Llatjós, Ana Montes, Rosa Penín, Ignacio Escobar, Antoni Xaubet, Salud Santos, Frederic Manresa, Jordi Dorca and Maria Molina-Molina
    Citation: BMC Pulmonary Medicine 2014 14:120
  37. Bronchodilator medications are central to the symptomatic management of chronic obstructive pulmonary disease (COPD). Metered-dose inhalers (MDIs) are the most commonly used devices to deliver treatment to pat...

    Authors: Stephen Rennard, Charles Fogarty, Colin Reisner, Carlos Fernandez, Tracy Fischer, Michael Golden, Earl St Rose, Patrick Darken, Gregory Tardie and Chadwick Orevillo
    Citation: BMC Pulmonary Medicine 2014 14:118
  38. Exposure to secondhand smoke (SHS) is a serious global public health problem. Understanding the correlates of SHS exposure could guide the development of evidence based SHS exposure reduction interventions. Th...

    Authors: Abu S Abdullah, Pete Driezen, Genevieve Sansone, Nigar Nargis, Ghulam AKM Hussain, Anne CK Quah and Geoffrey T Fong
    Citation: BMC Pulmonary Medicine 2014 14:117
  39. In healthy lungs, deposited micrometer-sized particles are efficiently phagocytosed by macrophages present on airway surfaces; however, uptake of nanoparticles (NP) by macrophages appears less effective and is...

    Authors: Marianne Geiser, Christoph Wigge, Melanie L Conrad, Sylvie Eigeldinger-Berthou, Lisa Künzi, Holger Garn, Harald Renz and Marcus A Mall
    Citation: BMC Pulmonary Medicine 2014 14:116
  40. Glutamine (GLN) has been reported to improve clinical and experimental sepsis outcomes. However, the mechanisms underlying the actions of GLN remain unclear, and may depend upon the route of GLN administration...

    Authors: Yin-Ching Chuang, Huey-Mei Shaw, Chi-Chung Chen, He-Jia Pan, Wei-Chih Lai and Hui-Ling Huang
    Citation: BMC Pulmonary Medicine 2014 14:115
  41. Obstructive sleep apnea (OSA) is associated with increased risk for cardiovascular morbidity and mortality. Epidemiological and animal models studies generate hypotheses for innovative strategies in OSA manage...

    Authors: Jose M Marin, Jorge Artal, Teresa Martin, Santiago J Carrizo, Marta Andres, Inmaculada Martin-Burriel, Rosa Bolea, Arianne Sanz, Luis Varona, Javier Godino, Begoña Gallego, Jose A Garcia-Erce, Isabel Villar, Victoria Gil, Marta Forner, Jose P Cubero…
    Citation: BMC Pulmonary Medicine 2014 14:114
  42. Inhaled corticosteroids are a mainstay of therapy for persistent asthma, but suboptimal adherence with twice-daily use is widespread. Fluticasone furoate (FF) is a new inhaled corticosteroid (ICS) suitable for...

    Authors: Ashley Woodcock, Jan Lötvall, William W Busse, Eric D Bateman, Sally Stone, Anna Ellsworth and Loretta Jacques
    Citation: BMC Pulmonary Medicine 2014 14:113
  43. Eosinophilic airway inflammation is observed in 10-30% of COPD subjects. Whether increased eosinophils or impairment in their clearance by macrophages is associated with the severity and frequency of exacerbat...

    Authors: Osama Eltboli, Mona Bafadhel, Fay Hollins, Adam Wright, Beverley Hargadon, Neeta Kulkarni and Christopher Brightling
    Citation: BMC Pulmonary Medicine 2014 14:112
  44. The impact of air pollution on the respiratory system has been estimated on the basis of respiratory symptoms and lung function. However; few studies have compared lung inflammation in healthy and asthmatics c...

    Authors: Benigno Linares Segovia, Gabriela Cortés Sandoval, Norma Amador Licona, Juan Manuel Guízar Mendoza, Estela Núñez Lemus, Diana Olivia Rocha Amador, Xóchitl Sofía Ramírez Gómez and Rebeca Monroy Torres
    Citation: BMC Pulmonary Medicine 2014 14:111
  45. Improvements in asthma diagnosis and management require deeper understanding of the heterogeneity of the complex airway inflammation. We hypothesise that differences in the two major inflammatory phenotypes of...

    Authors: Maria Bergquist, Sofia Jonasson, Josephine Hjoberg, Göran Hedenstierna and Jörg Hanrieder
    Citation: BMC Pulmonary Medicine 2014 14:110
  46. This paper describes the background, aim, and design of a prospective birth-cohort study in Korea called the COhort for Childhood Origin of Asthma and allergic diseases (COCOA). COCOA objectives are to investi...

    Authors: Hyeon-Jong Yang, So-Yeon Lee, Dong In Suh, Youn Ho Shin, Byoung-Ju Kim, Ju-Hee Seo, Hyoung Yoon Chang, Kyung Won Kim, Kangmo Ahn, Yee-Jin Shin, Kyung-Sook Lee, Cheol Min Lee, Se-Young Oh, Ho Kim, Jong-Han Leem, Hwan-Cheol Kim…
    Citation: BMC Pulmonary Medicine 2014 14:109
  47. Many asthmatic women complain of symptom exacerbations in particular periods, i.e. during pregnancy and menstrual cycles (perimenstrual asthma: PMA)". The goal of this study was to study the effect of the lute...

    Authors: Maria Matteis, Francesca Polverino, Giuseppe Spaziano, Fiorentina Roviezzo, Carlo Santoriello, Nikol Sullo, Maria Rosaria Bucci, Francesco Rossi, Mario Polverino, Caroline A Owen and Bruno D’Agostino
    Citation: BMC Pulmonary Medicine 2014 14:108
  48. We aimed to determine adherence to inhaled antibiotics, other respiratory medicines and airway clearance and to determine the association between adherence to these treatments and health outcomes (pulmonary ex...

    Authors: Amanda R McCullough, Michael M Tunney, Alexandra L Quittner, J Stuart Elborn, Judy M Bradley and Carmel M Hughes
    Citation: BMC Pulmonary Medicine 2014 14:107

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    2,422,461 downloads
    1,250 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal